Phathom Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks.

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price shot up 11.8% during mid-day trading on Monday . The company traded as high as $11.23 and last traded at $11.22. 489,633 shares were traded during trading, a decline of 40% from the average session volume of 809,964 shares. The stock had previously closed at […]

Stifel Nicolaus initiated coverage on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $24.00 price objective on the stock. Separately, Needham & Company LLC restated a buy rating and set a $26.00 price objective on shares of Phathom […]

Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Stifel Nicolaus assumed coverage on shares of Phathom Pharmaceuticals in a research report on Friday. They set […]